| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |